Oral propranolol as a new treatment for facial infantile hemangioma: case report
Hemangiomas are the most common benign tumors of infancy. Despite their self-limited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects.
Main Authors: | , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Conselho Brasileiro de Oftalmologia
2011
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000300012 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0004-27492011000300012 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0004-274920110003000122011-09-02Oral propranolol as a new treatment for facial infantile hemangioma: case reportFerreira,Rosane da CruzWolff,Francisco Romeu LocatelliMörschbächer,Ricardo Hemangioma Hemangioma, capillary/therapy Propranolol/therapeutic use Case reports Infant, newborn Hemangiomas are the most common benign tumors of infancy. Despite their self-limited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects.info:eu-repo/semantics/openAccessConselho Brasileiro de OftalmologiaArquivos Brasileiros de Oftalmologia v.74 n.3 20112011-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000300012en10.1590/S0004-27492011000300012 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Ferreira,Rosane da Cruz Wolff,Francisco Romeu Locatelli Mörschbächer,Ricardo |
spellingShingle |
Ferreira,Rosane da Cruz Wolff,Francisco Romeu Locatelli Mörschbächer,Ricardo Oral propranolol as a new treatment for facial infantile hemangioma: case report |
author_facet |
Ferreira,Rosane da Cruz Wolff,Francisco Romeu Locatelli Mörschbächer,Ricardo |
author_sort |
Ferreira,Rosane da Cruz |
title |
Oral propranolol as a new treatment for facial infantile hemangioma: case report |
title_short |
Oral propranolol as a new treatment for facial infantile hemangioma: case report |
title_full |
Oral propranolol as a new treatment for facial infantile hemangioma: case report |
title_fullStr |
Oral propranolol as a new treatment for facial infantile hemangioma: case report |
title_full_unstemmed |
Oral propranolol as a new treatment for facial infantile hemangioma: case report |
title_sort |
oral propranolol as a new treatment for facial infantile hemangioma: case report |
description |
Hemangiomas are the most common benign tumors of infancy. Despite their self-limited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects. |
publisher |
Conselho Brasileiro de Oftalmologia |
publishDate |
2011 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000300012 |
work_keys_str_mv |
AT ferreirarosanedacruz oralpropranololasanewtreatmentforfacialinfantilehemangiomacasereport AT wolfffranciscoromeulocatelli oralpropranololasanewtreatmentforfacialinfantilehemangiomacasereport AT morschbacherricardo oralpropranololasanewtreatmentforfacialinfantilehemangiomacasereport |
_version_ |
1756373144745017344 |